The rate of Entecavir resistance in Naïve and Lamivudine-resistance chronic hepatitis B patients during 3 years of treatment
Colonno RJ. AASLD 2006. Abstract 110.Copyright information:Taken from "The role of entecavir in the treatment of chronic hepatitis B"Therapeutics and Clinical Risk Management 2007;3(6):1077-1086.Published online Jan 2007PMCID:PMC2387288.© 2007 Dove Medical Press Limited. All rights reserve...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Bild |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Colonno RJ. AASLD 2006. Abstract 110.Copyright information:Taken from "The role of entecavir in the treatment of chronic hepatitis B"Therapeutics and Clinical Risk Management 2007;3(6):1077-1086.Published online Jan 2007PMCID:PMC2387288.© 2007 Dove Medical Press Limited. All rights reserved |
---|---|
DOI: | 10.6084/m9.figshare.89010 |